VERACYTE INC's ticker is VCYT and the CUSIP is 92337F107. A total of 167 filers reported holding VERACYTE INC in Q2 2020. The put-call ratio across all filers is 1.47 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $121 | -13.6% | 5,408 | -1.5% | 0.01% | -16.7% |
| Q2 2023 | $140 | +13.8% | 5,492 | -0.6% | 0.01% | +20.0% |
| Q1 2023 | $123 | -6.8% | 5,524 | -0.3% | 0.01% | -16.7% |
| Q4 2022 | $132 | -99.9% | 5,543 | -7.3% | 0.01% | +50.0% |
| Q3 2022 | $99,000 | -26.7% | 5,978 | -11.7% | 0.00% | 0.0% |
| Q2 2022 | $135,000 | +132.8% | 6,771 | +219.2% | 0.00% | +300.0% |
| Q1 2022 | $58,000 | -42.6% | 2,121 | -13.1% | 0.00% | -50.0% |
| Q4 2021 | $101,000 | -12.2% | 2,442 | -1.6% | 0.00% | -33.3% |
| Q3 2021 | $115,000 | +11.7% | 2,482 | -3.9% | 0.00% | +50.0% |
| Q2 2021 | $103,000 | -25.9% | 2,582 | 0.0% | 0.00% | -33.3% |
| Q1 2021 | $139,000 | -28.7% | 2,582 | -35.0% | 0.00% | -25.0% |
| Q4 2020 | $195,000 | +51.2% | 3,975 | 0.0% | 0.00% | +33.3% |
| Q3 2020 | $129,000 | +25.2% | 3,975 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $103,000 | – | 3,975 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PERKINS CAPITAL MANAGEMENT INC | 119,680 | $2,672 | 2.65% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 239,571 | $5,349,620 | 1.62% |
| OBERWEIS ASSET MANAGEMENT INC/ | 597,540 | $13,343,068 | 1.42% |
| ARK Investment Management | 7,593,592 | $169,564,898 | 1.30% |
| Capital Impact Advisors, LLC | 32,969 | $736,198 | 1.23% |
| EFG Asset Management (North America) Corp. | 229,837 | $5,127,663 | 1.22% |
| Parkman Healthcare Partners LLC | 225,872 | $5,043,722 | 0.92% |
| Nikko Asset Management Americas, Inc. | 3,173,576 | $70,770,745 | 0.85% |
| Granite Investment Partners, LLC | 865,770 | $19,332,644 | 0.81% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 175,749 | $3,924,475 | 0.64% |